openPR Logo
Press release

Egyptian Ministry of Health invites Diapharm to exchange knowledge

10-16-2012 04:26 PM CET | Health & Medicine

Press release from: Diapharm

/ PR Agency: co-operate Wegener & Rieke GmbH
Cairo (EG), Muenster (DE), 11 October, 2012. At a 3-day workshop in Cairo, pharmaceutical service provider Diapharm ( presented the European regulations on medication demarcation areas to representatives of the Egyptian Ministry of Health. Currently, Egypt is revising its legislation regarding medical products, nutritional supplements and self-medication products and is considering, at least partially, taking into account EU legislation. The objective is to improve the availability of safer products.

“Diapharm provided us with insights into EU regulatory practice and to some extent, different national implementations.” summarised Safa Ibrahim, responsible for implementing the medical devices regulation at the Egyptian Ministry of Health. GlaxoSmithKline Middle East had facilitated the contact. Dr. Guido Middeler and Dorothee Klöpf from Diapharm were invited to present to approximately 40 participants from various departments of the Ministry, the EU regulations on medical products and their demarcation from herbal medicinal products and nutritional supplements.

To some extent the experts also made a case for approaches that go beyond those of the European Union. “An orientation to the regulatory model of the Global Harmonization Task Force for medical products is to be recommended, on which, the EU, the USA, Canada, Australia and Japan are working” emphasized Dr. Guido Middeler: “In this way, Egypt would directly achieve maximum international harmonization and safer products would be more speedily available.” Among other topics discussed in the Cairo workshop was whether joint solutions that went beyond national borders might be meaningful.

(ca. 1,680 characters)

Diapharm is an international full-service provider to the healthcare industry. Founded in 1988, Diapharm supports pharmaceutical companies in all questions concerning regulatory affairs, medical & clinical development, quality management and business development. Its activities focus on the sectors of medicinal products, food supplements and dietetic food, medical devices and cosmetics. With about 100 employees in Germany, Austria and the United Kingdom, Diapharm is at the service of multinational companies as well as of recent start-ups and small to mid-sized businesses.

Press Office
Hafenweg 18-20
D-48155 Münster

Contact person:
Nicole Sibbing

Tel.: +49 (0)251 - 60935-517

Agency contact:
co-operate Wegener & Rieke GmbH
Zumsandestraße 32
D-48145 Münster

Contact person:
Christian Rieke

Tel.: +49 (0)251 - 3222611

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Egyptian Ministry of Health invites Diapharm to exchange knowledge here

News-ID: 239439 • Views:

More Releases from Diapharm

Diapharm assists in EU registration of Chinese medicines
Diapharm assists in EU registration of Chinese medicines
Diapharm ( has opened its representative office in Shanghai in July 2014 in reaction to a surging demand for pharmaceutical consultancy services in China. Diapharm helps pharmaceutical companies to obtain drug approval in Europe and assists them in quality assurance. “We will advise and assist Chinese companies as they make their way to Europe and also support European companies that purchase active ingredients or finished products from China and that
Diapharm implements European GMP guidelines in China
Diapharm implements European GMP guidelines in China
Münster (DE), London (UK), Ningbo (CN), 20 December 2013 – Pharmaceutical service provider Diapharm ( is increasing its business activities in China: Diapharm has now implemented a “European” quality management system for Neptune Pharma Ltd ( in their Joint Venture Partner’s factory in Ningbo, Zhejiang Province. And it has done so successfully: The veterinary medicinal product Trident 500mg/g Powder for Suspension for Fish Treatment (, is manufactured onsite under EU
A first for Portugal: Diapharm obtains registration for a traditional medicinal product with Agnus Castus
A first for Portugal: Diapharm obtains registration for a traditional medicinal …
Lisbon (PT), Münster, Oldenburg (DE), 25. June 2012 – Pharmaceutical service provider Diapharm ( has now also paved the way for traditional herbal medicinal products in Portugal. The Portuguese National Authority for Medicines and Health Products (INFARMED) has granted a second registration for a traditional medicinal product. “Historically, this type of registration is unusual for Portugal, and it is a sign that traditional herbal medicinal products for self-medication are gaining

All 4 Releases

More Releases for Egypt

Egypt Market Research Reports and Egypt Industry Research Reports
Egypt is an essential strategic partner of the United States and confirms to employ with the Egypt to develop mutually shared interests, comprising robust commercial ties. Egypt's strategic location proposes companies a platform for their commercial activities into the Middle East and Africa. U.S. exports to Egypt comprise agricultural goods, transportation equipment, chemicals, machinery, and computer & electronic products. U.S. imports from Egypt entail apparel, petroleum, processed foods, textiles, and
Egypt E-Learning Market, Egypt E-Learning Industry, Market Revenue: Ken Research
The report titled publication “Egypt E-Learning Market Outlook to 2026- Driven by easy and on-demand access to content, self-paced learning opportunities and interactive & modular means of learning” provides a comprehensive analysis of the Education Industry and K12 E-Learning Industry in Egypt. The report provides the industry size basis revenue and number of subscribers in the e-learning Industry in Egypt, supply ecosystem analysis, market segmentations, business model analysis, revenue stream
Egypt Dairy Packaging Market 2022 Global Insights and Business Scenario – Elif …
Market Insights Reports has added new statistical data to its repository titled as, Egypt Dairy Packaging Market. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data (as applicable). Furthermore, the report also sheds light on technological platforms, in addition to distinctive tools, and methodologies that will help to propel the performance of industries. The Egypt Dairy Packaging
Egypt Dairy Packaging Market 2021-2026 skyrocketed revenue with key players Elif …
Latest research on Egypt Dairy Packaging Market report covers forecast and analysis on a worldwide, regional and country level. The study provides historical information of 2016-2021 together with a forecast from 2021 to 2026 supported by both volume and revenue (USD million). The entire study covers the key drivers and restraints for the Egypt Dairy Packaging market. This report included a special section on the Impact of COVID19. Also, Egypt
Egypt: Country Intelligence Report | Vodafone Egypt, Orange Egypt, Telecom Egypt
HTF Market Intelligence released a new research report of 42 pages on title 'Egypt: Country Intelligence Report' with detailed analysis, forecast and strategies. The market Study is segmented by key a region that is accelerating the marketization. The study is a perfect mix of qualitative and quantitative Market data collected and validated majorly through primary data and secondary sources. The study covers key regions that includes Egypt and important
Telecom Operators Market in Egypt Country Intelligence Report 2021-2026 | Vodafo …
Latest published market study on Egypt Telecom Operators Country Intelligence Market provides an overview of the current market dynamics in the Egypt Telecom Operators Country Intelligence space, as well as what our survey respondents—all outsourcing decision-makers—predict the market will look like in 2027. The study breaks market by revenue and volume (wherever applicable) and price history to estimates size and trend analysis and identifying gaps and opportunities. Some of the